Stroke is a leading cause of disability and death worldwide. Early recognition and prompt management of stroke can significantly improve patient outcomes. This article provides a comprehensive guide for healthcare professionals in recognizing and managing stroke in its early stages.
A stroke occurs when blood flow to a part of the brain is interrupted, leading to rapid loss of brain function. The acronym F.A.S.T. (Face, Arms, Speech, Time) is a simple tool that can help in early recognition. Facial drooping, arm weakness, speech difficulties are warning signs of a stroke. Time is critical in stroke management; the sooner the patient receives medical care, the better the prognosis.
Upon suspicion of a stroke, a rapid neurological assessment should be performed. The National Institutes of Health Stroke Scale (NIHSS) is a valuable tool for quantifying stroke severity. A higher score on the NIHSS correlates with more severe strokes and worse outcomes.
Imaging plays a crucial role in the early management of stroke. A non-contrast CT scan of the head is typically the first imaging modality used to differentiate between ischemic and hemorrhagic stroke. Advanced imaging techniques like CT angiography and perfusion imaging can provide additional information about the extent of the stroke and the presence of salvageable brain tissue.
Once a stroke is confirmed, immediate treatment is necessary. For ischemic strokes, intravenous thrombolysis with alteplase is the first-line treatment if administered within 4.5 hours of symptom onset. In selected cases, endovascular therapy may be beneficial. For hemorrhagic strokes, controlling blood pressure and reversing anticoagulation are crucial initial steps.
Early recognition and management of stroke can significantly improve patient outcomes. Healthcare professionals play a critical role in this process. By staying updated on the latest evidence-based practices, we can ensure that our patients receive the best possible care in the crucial early stages of stroke.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation